If you are:
Only When Necessary: INSUFFICIENT HUMAN DATA AVAILABLE
Absolute Contraindication: EXCRETION IS LIKELY IN HUMANS; SERIOUS ADVERSE EFFECTS POSSIBLE
An adult over 60:
management or monitoring precaution: Urogenital-Use caution in those patients prone to urinary retention (bladder outflow obstruction, BPH).
Giving mirabegron Tablet, Extended Release 24 hr to a child under 12:
management or monitoring precaution: Safety and efficacy not established.